| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/07/2001 | EP1081225A1 Transgenic animal model for neurodegenerative diseases |
| 03/07/2001 | EP1081099A1 Bioremediation process using bacterivorous protozoa |
| 03/07/2001 | EP1080633A1 Method for transforming plant, the resultant plant and gene thereof |
| 03/07/2001 | EP1080219A1 Amphotropic retrovirus packaging cell line, process for its production and use thereof |
| 03/07/2001 | EP1080216A2 Retroviral delivery system |
| 03/07/2001 | EP1080210A2 Methods for producing a polypeptide by modifying the copy number of a gene |
| 03/07/2001 | EP1080208A1 Dsrna-mediated regulation of gene expression in plants |
| 03/07/2001 | EP1080206A1 Generation of multiple gene products from chimeric fusion proteins by cleavage with ubiqitous endoproteases |
| 03/07/2001 | EP1080200A1 Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4 |
| 03/07/2001 | EP1080199A2 (hemorrhagic enteritis) virus dna sequences, proteins encoded thereby and various uses thereof |
| 03/07/2001 | EP1080196A1 Polynucleotide sequences and their use in a method of producing plants with an increased number of stomata |
| 03/07/2001 | EP1080195A1 Endometriosis-associated gene |
| 03/07/2001 | EP1080190A1 Calmodulin related protein |
| 03/07/2001 | EP1080189A1 Compositions and methods for the synthesis of fatty acids, their derivatives and downstream products |
| 03/07/2001 | EP1080188A2 Human nucleic acid sequences of uterus myoma tissue |
| 03/07/2001 | EP1080187A2 Modification of cereal grain hardness via expression of puroindoline proteins |
| 03/07/2001 | EP1080186A2 Method for altering the activity of proteins of the pka signaling pathway |
| 03/07/2001 | EP1080185A2 Myelin basic protein peptides and uses thereof |
| 03/07/2001 | EP1080184A1 Method for activating natural killer (nk) cells |
| 03/07/2001 | EP1080183A1 Promotion of cell differentiation by initially passaged cells |
| 03/07/2001 | EP1080182A1 Amino acid modified polypeptides |
| 03/07/2001 | EP1080181A1 clpX OF STREPTOCOCCUS PNEUMONIAE |
| 03/07/2001 | EP1080180A2 Secreted proteins and polynucleotides encoding them |
| 03/07/2001 | EP1080111A2 The induction of antiobiotic peptides by lait (scd14) protein |
| 03/07/2001 | EP1080106A1 Secreted proteins and polynucleotides encoding them |
| 03/07/2001 | EP1080100A1 Cytosine deaminase gene |
| 03/07/2001 | EP1080057A1 Genes encoding epsilon lycopene cyclase and method for producing bicyclic epsilon carotene |
| 03/07/2001 | EP1079858A2 Oral immunization with papillomavirus virus-like particles |
| 03/07/2001 | EP1079856A1 Humanized antibodies that recognize verotoxin ii and cell line producing same |
| 03/07/2001 | EP1079848A1 Angiostatin receptor |
| 03/07/2001 | EP1079844A1 Chaperone suppression of ataxin-1 aggregation and altered subcellular proteasome localization imply protein misfolding in sca1 |
| 03/07/2001 | EP1079824A1 Triterpene compositions and methods for use thereof |
| 03/07/2001 | EP1079772A1 Corporal tissue penile reconstruction |
| 03/07/2001 | EP1079688A1 Method for expanding primate b cells selectively in immunocompromised mice and producing large numbers of antigen-specific b lymphocytes for the production of primate monoclonal antibodies |
| 03/07/2001 | EP0918874B1 Self-replicating episomal expression vectors conferring tissue-specific gene expression |
| 03/07/2001 | EP0486526B2 Tumour necrosis factor binding ligands |
| 03/07/2001 | CN1286726A Histamine and serotonin binding molecules |
| 03/07/2001 | CN1286724A Bleaching compositions comprising multiply-substd, protease variants |
| 03/07/2001 | CN1286723A Cleaning compositions contg. multiply-substd-protease variants |
| 03/07/2001 | CN1286697A NPCAHH01: human transmembrane protein E3-16 gene |
| 03/07/2001 | CN1062908C Polypeptides and DNAs encoding them |
| 03/07/2001 | CN1062907C Method for preparation of antibody materials |
| 03/06/2001 | US6198022 Transgenic plants belonging to the species Cucumis melo |
| 03/06/2001 | US6198021 Transgenic plant or seed which produces enzymatic polypeptide; for the prevention of flowering in plants; for the prevention of premature seed germination; for amplifying plants tolerance to freezing, dryness and fungal infection |
| 03/06/2001 | US6197939 Polypeptide regulator; for use as a diagnostic tool in detection of tumors |
| 03/06/2001 | US6197931 Human marco scavenger receptor |
| 03/06/2001 | US6197925 NF-AT polypeptides and polynucleotides |
| 03/06/2001 | US6197754 Tyrosine kinase inhibitor |
| 03/06/2001 | US6197745 Methods for producing nitrosated hemoglobins and therapeutic uses therefor |
| 03/06/2001 | US6197591 Nucleotide sequence which control the transcription of a preferential antibiotic |
| 03/06/2001 | US6197586 Chondrocyte-like cells useful for tissue engineering and methods |
| 03/06/2001 | US6197585 Producing neuronal tissues; immortalizing neuronal stem cells tissues, culturing tissues, terminating immortalization and allowing differentiation into brain tissues |
| 03/06/2001 | US6197582 Development of human monoclonal antibodies and uses thereof |
| 03/06/2001 | US6197581 Human adenylate cyclase and use therefor |
| 03/06/2001 | US6197580 Transcriptional regulation of the human β3-adrenergic receptor gene |
| 03/06/2001 | US6197578 Cells expressing both human CD4 and a human fusion accessory factor associated with HIV infection |
| 03/06/2001 | US6197551 Spoil-1 protein and nucleic acid molecules and uses therefor |
| 03/06/2001 | US6197542 Protecting plants or plant cells against rna virus whose replication depends on viral rna/rna polymerase by preparing expression cassette having defective viral replicon between two inverted repeats, and incorporating into plant genome |
| 03/06/2001 | US6197541 Nucleic acid which codes for mammalian receptor having seven transmembrane domains; drug screening of anticoagulants and wound healing agents; diagnosis of cardiovascular disorders; treatment of restenosis and unstable angina |
| 03/06/2001 | US6197530 GPR10 as a target for identifying weight modulating compounds |
| 03/06/2001 | US6197525 Kit for detection of interleukin-17, interleukin-17 receptor, antagonists, or mimetics; includes receptor protein of defined amino acid sequence and a detecting reagent; for identifying immunosuppressants |
| 03/06/2001 | US6197524 Methods for detecting, identifying, isolating, and selectively labelling and targeting TH1 lymphocyte by means of the LAG-3 protein |
| 03/06/2001 | US6197521 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
| 03/06/2001 | US6197519 Pancreas-derived serpin |
| 03/06/2001 | US6197511 Amino acid sequence; diagosis and treatment of cancer and skin disorders; anticarcinogenic agents; recombinant production; hybridization probes |
| 03/06/2001 | US6197330 System for the treatment of wounds |
| 03/06/2001 | US6197325 Supplemented and unsupplemented tissue sealants, methods of their production and use |
| 03/06/2001 | US6197301 Compositions and methods for the prevention and diagnosis of Lyme disease |
| 03/06/2001 | US6197297 Monoclonal antibody specific to polypeptide which induces interferon-gamma production |
| 03/06/2001 | US6197296 Forming a contracted gel from an aqueous mixture of collagen fibrils, a nutrient medium and a cellular contractile agent, lining the gel with endothelial cells to obtain tissue equivalent, applying aqueous fluid to tissue |
| 03/06/2001 | US6197294 Cells containing recombinant polynucleotides coding for cell surface molecules that, when expressed in the cell, result in rejection of the cell by host cell by host immune system; useful for gene therapy |
| 03/06/2001 | US6197293 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof |
| 03/06/2001 | US6197069 Adrenomedullin receptor polynucleotides |
| 03/06/2001 | US6197061 In vitro production of transplantable cartilage tissue cohesive cartilage produced thereby, and method for the surgical repair of cartilage damage |
| 03/06/2001 | CA1341198C Monoclonal antibodies against melanoma-associated antigens, hybrid cell lines producing these antibodies, and use therefor |
| 03/01/2001 | WO2001014578A1 Methods for the detection, analysis and isolation of nascent proteins |
| 03/01/2001 | WO2001014572A2 Plant gene expression, controlled by constitutive plant v-atpase promoters |
| 03/01/2001 | WO2001014564A2 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
| 03/01/2001 | WO2001014556A1 Novel b7-4 molecules and uses therefor |
| 03/01/2001 | WO2001014555A1 Human narcolepsy gene |
| 03/01/2001 | WO2001014554A1 G protein-coupled receptor expressed in brain |
| 03/01/2001 | WO2001014551A1 NOVEL bHLH TYPE TRANSCRIPTION FACTOR GENE DEC2 |
| 03/01/2001 | WO2001014549A1 Gas1 polypeptides |
| 03/01/2001 | WO2001014548A2 New g-protein coupled receptor and dna sequences thereof |
| 03/01/2001 | WO2001014547A1 Novel abc transporter and uses thereof |
| 03/01/2001 | WO2001014545A1 Pgrp-l polynucleotides, polypeptides, and antibodies |
| 03/01/2001 | WO2001014544A1 Novel response element |
| 03/01/2001 | WO2001014542A1 A transmembrane trap for isolating membrane bound proteins |
| 03/01/2001 | WO2001014539A2 Methods and compositions for the construction and use of fusion libraries |
| 03/01/2001 | WO2001014538A2 Plants with modified polyunsaturated fatty acids |
| 03/01/2001 | WO2001014536A2 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 03/01/2001 | WO2001014535A2 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-β1,3-N-ACETYLGALACTOSAMINE-α-R/(GlcNAc to GalNAc) β1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3 |
| 03/01/2001 | WO2001014533A2 Phosphomevalonate kinase (pmk) gene (erg8) from candida albicans |
| 03/01/2001 | WO2001014530A2 Method for growing stem cells |
| 03/01/2001 | WO2001014529A1 Compositions and methods for improved cell culture |
| 03/01/2001 | WO2001014528A1 Method of preparing immune response-inducing dendritic cells |
| 03/01/2001 | WO2001014527A1 Skin care compositions and treatments |
| 03/01/2001 | WO2001014424A2 Human ctla-4 antibodies and their uses |
| 03/01/2001 | WO2001014421A1 Homologs of a pneumococcal protein and fragments for vaccines |
| 03/01/2001 | WO2001014418A2 p193 PROTEINS AND NUCLEIC ACIDS, AND USES THEREOF |